Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.259
-4.18 %
$ 2.59 M
Market Cap
-0.04
P/E
INCOME STATEMENT
5.82 M
REVENUE
-13.6 M
OPERATING INCOME
-8.16 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Petros Pharmaceuticals, Inc.
| Revenue | 5.82 M |
| Cost Of Revenue | 1.63 M |
| Gross Profit | 4.19 M |
| Operating Expenses | 17.8 M |
| Operating Income | -13.6 M |
| Other Expenses | -5.45 M |
| Net Income | -8.16 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 5.8 | 6.0 | 7.8 | 9.6 | 15.6 | 14.1 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.6 | 2.3 | 1.6 | 4.0 | 7.4 | 10.5 |
| Gross Profit | 4.2 | 3.7 | 6.2 | 5.5 | 8.2 | 3.6 |
| OPERATING INCOME | ||||||
| Operating Expenses | 17.8 | 19.5 | 24.3 | 22.8 | 25.0 | 11.2 |
| Selling, General and Administrative Expenses | 9.3 | 12.2 | 15.6 | 15.7 | 19.7 | 11.2 |
| Research and Development Expenses | 2.4 | 1.7 | 1.8 | 0.5 | 0 | 0 |
| Operating Income | (13.6) | (15.8) | (18.0) | (17.3) | (16.9) | (7.7) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0.5 | 0.6 | 0.4 | 3.1 | 13.8 | 0 |
| Total Other Income | 5.5 | (0.1) | 9.1 | (4.7) | (13.8) | (24.8) |
| Pre-Tax Income | (8.2) | (20.0) | (9.0) | (22.0) | (33.2) | (32.5) |
| NET INCOME | ||||||
| Tax Provision | 0 | 7.0 | 0.4 | (1.4) | (0.6) | 13.4 K |
| Net Income | (8.2) | (27.0) | (9.4) | (20.6) | (32.5) | (32.5) |
| EPS | 6.35 | 13.1 | 8.59 | 21.2 | 190 | 325 |